Albireo to Showcase New Data at AASLD The Liver Meeting®
– Seven abstracts accepted, including one oral presentation highlighting long-term data demonstrating Bylvay® (odevixibat) durable efficacy in patients...
Source: globenewswire.com
Stay updated with breaking news from Beatrix Children. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Seven abstracts accepted, including one oral presentation highlighting long-term data demonstrating Bylvay® (odevixibat) durable efficacy in patients...
In children with pulmonary arterial hypertension, early initiation of IV or subcutaneous parenteral prostanoid therapy, higher doses of therapy and when combined with additional PAH therapy were associated with favorable outcomes.“Currently, IV/subcutaneous prostanoids are not formally approved for children by the Europeans Medicines Agency or the U.S. FDA, but generally used as an accepted